Since our results suggest that transient knockdown of HDAC2 exerts potent anti-tumor activity, we next investigated if sustained suppression of HDAC2 can attenuate tumorigenic potential of HCC cells in vitro and in vivo. This evidence concerns the gene HDAC2 and neoplasm.